- Q4 2024 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 27, 2024₹1120.3 (+8.20%)Earnings
- Q2 2024 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 15, 2023₹750.6 (+3.60%)Earnings
- Q1 2024 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 14, 2023₹797.55 (-0.51%)Earnings
- Full Year 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 22, 2023₹605.2 (-3.04%)Earnings
- Q3 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 13, 2023₹422.8 (+5.74%)Earnings
- Q2 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 14, 2022₹430.65 (+3.98%)Earnings
- Q1 2023 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 12, 2022₹389 (+0.82%)Earnings
- Full Year 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 30, 2022₹409.5 (+2.88%)Earnings
- Q3 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 14, 2022₹478.45 (-2.28%)Earnings
- Q2 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 15, 2021₹535.75 (+2.31%)Earnings
- Q1 2022 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 16, 2021₹569.4 (+1.10%)Earnings
- Full Year 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 31, 2021₹592.6 (-2.39%)Earnings
- Q3 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 15, 2021₹490.65 (-2.69%)Earnings
- Q2 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 09, 2020₹481.35 (-5.89%)Earnings
- Q1 2021 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 17, 2020₹480.9 (+1.16%)Earnings
- Full Year 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptJun 29, 2020₹467.5 (+0.14%)Earnings
- Hindustan Unilever Ltd to Acquire Intimate Hygiene Brand 'VWash' from Glenmark Pharmaceuticals Ltd Call TranscriptMar 23, 2020
- Q3 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptFeb 17, 2020₹310.4 (-6.97%)Earnings
- Q2 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptNov 15, 2019₹301.2 (+6.70%)Earnings
- Q1 2020 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptAug 14, 2019₹383.9 (-7.94%)Earnings
- Full Year 2019 Glenmark Pharmaceuticals Ltd Earnings Call TranscriptMay 30, 2019₹555.35 (+1.46%)Earnings
Full Year 2020 Glenmark Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Q4 FY '20 Earning Conference Call of Glenmark Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.
I would now like to hand the conference over to Mr. Jason D'souza. Thank you, and over to you, sir.
' -
Thank you, moderator. Welcome to Glenmark's Q4 Earnings Call. Before I start the call, I would like to introduce the members at Glenmark. We have Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals; V. S. Mani, our Executive Director and CFO, Glenmark Pharmaceuticals; and Robert Matsuk, President, North America.
First, the review of operations for the fourth quarter ended March 31, 2020. For the fourth quarter, Glenmark's consolidated revenue was at INR 27,674 million, recording an increase of INR 796 million (sic) [7.96%]. For the year ended, Glenmark's consolidated revenue was INR 106,406.69 million (sic) [INR 106,409.69
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)